Literature DB >> 22996389

Dissociation of c-Met phosphotyrosine sites in human cells in response to mouse hepatocyte growth factor but not human hepatocyte growth factor: the possible roles of different amino acids in different species.

Fumie Ikebuchi1, Kiyomasa Oka, Shinya Mizuno, Kazuhiro Fukuta, Daichika Hayata, Hiroyuki Ohnishi, Toshikazu Nakamura.   

Abstract

Hepatocyte growth factor (HGF) is essential for embryogenesis, tissue regeneration and tumour malignancy through the activation of its receptor, c-Met. We previously demonstrated that HGF α-chain hairpin-loop, K1 domain and β-chain are required for c-Met signalling. The sequential phosphorylation of tyrosine residues, from c-Met kinase domain to multidocking regions, is required for HGF-signalling transduction. Herein, we provide evidence that the disconcerted activation of c-Met tyrosine regions fails to induce biological functions. When human cells were incubated with 'mouse HGF', kinase domain activation (i.e. phospho-Tyr-1230/34/35) became evident, but the multidocking site (i.e. Tyr-1349) was not phosphorylated, resulting in unsuccessful induction of migration and mitogenesis. The binding ability of mouse HGF α-chain, or of β-chain, to human c-Met was lower than that of human HGF, as evidenced by HGF-chimera assay. Notably, only four amino acid positions in HGF α-chain hairpin-loop and K1 domain and six positions in β-chain differed between human HGF and mouse HGF. The human-specific amino acids (such as Gln-95 in hairpin-loop, Arg-134 in K1 domain and Cys-561 in β-chain) may be important for accurate c-Met assembly and signalling transduction.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22996389     DOI: 10.1002/cbf.2898

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  9 in total

1.  Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies.

Authors:  Stacey Bagby; Wells A Messersmith; Todd M Pitts; Anna Capasso; Marileila Varella-Garcia; Peter J Klauck; Jihye Kim; Aik-Choon Tan; S Gail Eckhardt; John J Tentler; John Arcaroli
Journal:  J Vis Exp       Date:  2016-09-30       Impact factor: 1.355

2.  Inhibition of ligand-independent constitutive activation of the Met oncogenic receptor by the engineered chemically-modified antibody DN30.

Authors:  Elisa Vigna; Cristina Chiriaco; Simona Cignetto; Lara Fontani; Cristina Basilico; Fiorella Petronzelli; Paolo M Comoglio
Journal:  Mol Oncol       Date:  2015-06-05       Impact factor: 6.603

3.  Association between Hepatocyte Growth Factor (HGF) Gene Polymorphisms and Serum HGF Levels in Patients with Rheumatoid Arthritis.

Authors:  Fatih Kara; Abdulkadir Yildirim; Musa Gumusdere; Saliha Karatay; Kadir Yildirim; Ebubekir Bakan
Journal:  Eurasian J Med       Date:  2014-08-26

4.  Stroma-derived HGF drives metabolic adaptation of colorectal cancer to angiogenesis inhibitors.

Authors:  Alessia Mira; Virginia Morello; Maria Virtudes Céspedes; Timothy Perera; Paolo M Comoglio; Ramon Mangues; Paolo Michieli
Journal:  Oncotarget       Date:  2017-06-13

5.  The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness.

Authors:  Ulrike Schmidt; Gerwin Heller; Gerald Timelthaler; Petra Heffeter; Zsolt Somodi; Norbert Schweifer; Maria Sibilia; Walter Berger; Agnes Csiszar
Journal:  J Exp Clin Cancer Res       Date:  2021-02-17

6.  A receptor-antibody hybrid hampering MET-driven metastatic spread.

Authors:  Chiara Modica; Cristina Basilico; Cristina Chiriaco; Nicla Borrelli; Paolo M Comoglio; Elisa Vigna
Journal:  J Exp Clin Cancer Res       Date:  2021-01-14

7.  Hepatocyte growth factor overexpression promotes osteoclastogenesis and exacerbates bone loss in CIA mice.

Authors:  Chaoming Huang; Yufan Zheng; Jinyu Bai; Ce Shi; Xin Shi; Huajian Shan; Xiaozhong Zhou
Journal:  J Orthop Translat       Date:  2020-12-10       Impact factor: 5.191

8.  Mammary Tumor Cells with High Metastatic Potential Are Hypersensitive to Macrophage-Derived HGF.

Authors:  Takanori Kitamura; Yu Kato; Demi Brownlie; Daniel Y H Soong; Gaël Sugano; Nicolle Kippen; Jiufeng Li; Dahlia Doughty-Shenton; Neil Carragher; Jeffrey W Pollard
Journal:  Cancer Immunol Res       Date:  2019-10-15       Impact factor: 11.151

9.  Cross-talk between human airway epithelial cells and 3T3-J2 feeder cells involves partial activation of human MET by murine HGF.

Authors:  Robert E Hynds; Kate H C Gowers; Ersilia Nigro; Colin R Butler; Paola Bonfanti; Adam Giangreco; Cecilia M Prêle; Sam M Janes
Journal:  PLoS One       Date:  2018-05-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.